ftInvstr
SYNGENE · Healthcare ₹436.0 +0.3% Mkt Cap ₹17568 Cr overvalued

SYNGENE

Healthcare Diagnostics & Research
₹436.0
+0.3% today · 30d +25.98%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for SYNGENE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹833 Cr
-8.55% YoY
NET PROFIT
₹32 Cr
-52.01% YoY
OPM
20.38%
-2.83pp YoY
EPS
₹0.8
PE 95.85
Intrinsic value · DCF ₹52.18 · Margin of safety -88.0% (overvalued) · FCF yield 3.25%
◇ Sector Position
PEERPEROCE %
SYNGENE95.8510.0
SAILIFE103.8124.25
LALPATHLAB57.3731.74
VIJAYA74.425.86
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
48
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation STRETCHED 20
Growth MUTED 39
Profitability DECENT 68
Technicals NEUTRAL 65
Risk LOW 90
Key Stats
TTM PE
95.85
P/B
3.67
52W HIGH
₹678.95
OFF HIGH
-35.78%
DIV YIELD
0.29%
MKT CAP
₹17568 Cr
◉ Active Signals
MACDBullish5.307
RSI(14)Bullish66.79
Street Consensus
8 analysts
₹510.0
mean target
Low ₹400.0Now ₹436.0High ₹735.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SYNGENE and at what entry.

Sign up freeSign in